Skip to content

Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)

Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04561193
Enrollment
417
Registered
2020-09-23
Start date
2020-05-30
Completion date
2022-05-23
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals

Detailed description

Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals (Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas) between February 1 and April 30, 2020. All study center utilize Epic ® electronic health record (Verona, Wisconsin; www.epic.com) for which all data will be extracted from.

Interventions

OTHERObservational

Observational

Sponsors

Methodist Health System
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients admitted to Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas Medical Centers between February 1, 2020 and April 30, 2020 * \>18 years old * Positive SARS-CoV-2 (COVID-19) PCR test

Exclusion criteria

* Outpatient or emergency department visit * Not admitted to an inpatient or observation status for \>24 hours

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of subsequent and co-infectionsFeb 2020 - April 2020Prevalence of subsequent and co-infections

Secondary

MeasureTime frameDescription
In-hospital mortalityFeb 2020 - April 2020In-hospital mortality
Hospital length of stay (LOS)Feb 2020 - April 2020Hospital length of stay (LOS)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMatthew Crotty, PharmD

Methodist Health System

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026